Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
RESEARCH TOOLSreports
NewAmsterdam Pharma Company (NAMS) Stock Price & Analysis
59 Followers
NAMS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.63 - $26.35
Previous Close$20.5
Volume244.05K
Average Volume (3M)190.97K
Market Cap
$1.84B
Enterprise Value$1.41B
Total Cash (Recent Filing)$438.52M
Total Debt (Recent Filing)$118.00K
Price to Earnings (P/E)N/A
Beta0.65
Next Earnings
Aug 05, 2024EPS Estimate
-$0.58Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding89,976,538
10 Day Avg. Volume116,822
30 Day Avg. Volume190,966
Standard Deviation0.23
R-Squared0.00561
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)-8.98
Price to Sales (P/S)18.92
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit38.11
Enterprise Value/Ebitda-602.09
Forecast
1Y Price Target
$37.00Price Target Upside86.77% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
NewAmsterdam Pharma Company News
PremiumPre-Earnings
Is NAMS a Buy, Before Earnings?
PremiumCompany Announcements
NewAmsterdam Pharma Announces Executive Leadership ChangesOwnership Overview
7.60% Insiders
0.73% Mutual Funds
73.94% Other Institutional Investors
17.74% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NAMS FAQ
What was NewAmsterdam Pharma Company’s price range in the past 12 months?
NewAmsterdam Pharma Company lowest stock price was $5.63 and its highest was $26.35 in the past 12 months.
What is NewAmsterdam Pharma Company’s market cap?
Currently, no data Available
When is NewAmsterdam Pharma Company’s upcoming earnings report date?
NewAmsterdam Pharma Company’s upcoming earnings report date is Aug 05, 2024 which is in 81 days.
How were NewAmsterdam Pharma Company’s earnings last quarter?
NewAmsterdam Pharma Company released its earnings results on May 09, 2024. The company reported -$1.06 earnings per share for the quarter, missing the consensus estimate of -$0.618 by -$0.442.
Is NewAmsterdam Pharma Company overvalued?
According to Wall Street analysts NewAmsterdam Pharma Company’s price is currently Undervalued.
Does NewAmsterdam Pharma Company pay dividends?
NewAmsterdam Pharma Company does not currently pay dividends.
What is NewAmsterdam Pharma Company’s EPS estimate?
NewAmsterdam Pharma Company’s EPS estimate is -$0.58.
How many shares outstanding does NewAmsterdam Pharma Company have?
NewAmsterdam Pharma Company has 89,976,540 shares outstanding.
What happened to NewAmsterdam Pharma Company’s price movement after its last earnings report?
NewAmsterdam Pharma Company reported an EPS of -$1.06 in its last earnings report, missing expectations of -$0.618. Following the earnings report the stock price went up 0.321%.
Which hedge fund is a major shareholder of NewAmsterdam Pharma Company?
Among the largest hedge funds holding NewAmsterdam Pharma Company’s share is Viking Global Investors LP. It holds NewAmsterdam Pharma Company’s shares valued at 90M.
---
NewAmsterdam Pharma Company Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$37.00 (86.77% Upside)
$37.00 (86.77% Upside)
Hedge Fund Trend
Decreased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $276.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 0.2%
Last 30 Days ▲ 0.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Company Description
NewAmsterdam Pharma Company
Frazier Lifesciences Acquisition Corp is a blank check company.
---
NAMS Stock 12 Month Forecast
Average Price Target
$37.00
▲(86.77% Upside)
Technical Analysis
Best Analysts Covering NAMS
1 Year
1 Year Success Rate
6/9 ratings generated profit
1 Year Average Return
+49.57%
reiterated a buy rating 8 days ago
Copying Roanna Ruiz's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +49.57% per trade.
---